Sanofi SA
SNY47.830USD
+0.340+0.72%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
115.64B시가총액
13.25P/E TTM
자세한 내용은 Sanofi SA 회사
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Sanofi SA 정보
종목 코드 SNY
회사 이름Sanofi SA
상장일Jul 01, 2002
CEOHudson (Paul)
직원 수84587
유형Depository Receipt
회계 연도 종료Jul 01
주소46 Avenue de la Grande Armee
도시PARIS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가France
우편 번호75017
전화33153774000
웹사이트https://www.sanofi.com/
종목 코드 SNY
상장일Jul 01, 2002
CEOHudson (Paul)
Sanofi SA의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas Kudsk Larsen
Mr. Thomas Kudsk Larsen
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
Ms. Rachel Duan
Ms. Rachel Duan
Independent Director
Independent Director
--
--
Ms. Lise Kingo
Ms. Lise Kingo
Independent Director
Independent Director
--
--
Ms. Natalie Bickford
Ms. Natalie Bickford
Chief People Officer, Executive Vice President, Member of the Executive Committee
Chief People Officer, Executive Vice President, Member of the Executive Committee
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas Kudsk Larsen
Mr. Thomas Kudsk Larsen
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
7.99B
54.99%
Rest of the World (Japan, South Korea, Canada, Australia, New Zealand)
3.51B
24.18%
Europe
3.03B
20.82%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sun, Nov 16
마지막 업데이트: Sun, Nov 16
주주
주주 유형
주주
주주
비율
Dodge & Cox
2.83%
Fisher Investments
0.52%
Barrow Hanley Global Investors
0.29%
Managed Account Advisors LLC
0.26%
T. Rowe Price Associates, Inc.
0.24%
기타
95.85%
주주
주주
비율
Dodge & Cox
2.83%
Fisher Investments
0.52%
Barrow Hanley Global Investors
0.29%
Managed Account Advisors LLC
0.26%
T. Rowe Price Associates, Inc.
0.24%
기타
95.85%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
4.92%
Investment Advisor
3.82%
Research Firm
0.80%
Hedge Fund
0.32%
Bank and Trust
0.10%
Family Office
0.02%
Pension Fund
0.02%
기타
90.01%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
1286
242.88M
9.98%
-25.07M
2025Q3
1269
251.34M
10.32%
-27.29M
2025Q2
1261
264.33M
10.86%
-14.23M
2025Q1
1286
268.29M
10.62%
-13.21M
2024Q4
1263
270.44M
10.70%
-30.67M
2024Q3
1239
286.03M
11.43%
-5.72M
2024Q2
1248
275.46M
11.01%
-5.50M
2024Q1
1232
261.25M
10.33%
-7.62M
2023Q4
1213
251.25M
9.93%
-18.33M
2023Q3
1178
256.18M
10.15%
-15.97M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Dodge & Cox
68.93M
2.83%
-2.79M
-3.89%
Sep 30, 2025
Fisher Investments
12.58M
0.52%
-556.62K
-4.24%
Sep 30, 2025
Barrow Hanley Global Investors
7.13M
0.29%
-153.54K
-2.11%
Sep 30, 2025
Managed Account Advisors LLC
6.44M
0.26%
-1.04M
-13.90%
Sep 30, 2025
T. Rowe Price Associates, Inc.
5.87M
0.24%
+347.79K
+6.30%
Sep 30, 2025
Invesco Advisers, Inc.
5.16M
0.21%
-3.40M
-39.74%
Sep 30, 2025
Wellington Management Company, LLP
4.12M
0.17%
-207.27K
-4.79%
Sep 30, 2025
Putnam Investment Management, L.L.C.
3.82M
0.16%
-310.38K
-7.52%
Sep 30, 2025
Boston Partners
3.68M
0.15%
-312.03K
-7.82%
Sep 30, 2025
Mondrian Investment Partners Ltd.
3.64M
0.15%
+195.92K
+5.69%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Fri, Dec 5
마지막 업데이트: Fri, Dec 5
이름
비율
VanEck Pharmaceutical ETF
10.04%
Invesco International Dividend Achievers ETF
3.05%
Altrius Global Dividend ETF
2.41%
Brandes US Value ETF
2.14%
Putnam Focused Large Cap Value ETF
1.9%
American Century Focused Large Cap Value ETF
1.42%
ProShares Ultra Nasdaq Biotechnology
1.33%
Invesco Nasdaq Biotechnology ETF
1.32%
Invesco ESG NASDAQ Next Gen 100 ETF
0.97%
Invesco NASDAQ Next Gen 100 ETF
0.74%
더 보기
VanEck Pharmaceutical ETF
비율10.04%
Invesco International Dividend Achievers ETF
비율3.05%
Altrius Global Dividend ETF
비율2.41%
Brandes US Value ETF
비율2.14%
Putnam Focused Large Cap Value ETF
비율1.9%
American Century Focused Large Cap Value ETF
비율1.42%
ProShares Ultra Nasdaq Biotechnology
비율1.33%
Invesco Nasdaq Biotechnology ETF
비율1.32%
Invesco ESG NASDAQ Next Gen 100 ETF
비율0.97%
Invesco NASDAQ Next Gen 100 ETF
비율0.74%
주식 배당금
지난 5년 동안 총
19.02B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Apr 15, 2025
SNY.NB Final Cash Dividend of gross USD 2.195331 paid on Jun 12, 2025 going ex on May 09, 2025
May 09, 2025
Jun 12, 2025
May 09, 2025
Mar 26, 2024
SNY.NB Final Cash Dividend of gross USD 2.036908 paid on Jun 06, 2024 going ex on May 09, 2024
May 10, 2024
Jun 06, 2024
May 09, 2024
Feb 15, 2023
SNY.NB Final Cash Dividend of gross USD 1.900085 paid on Jun 23, 2023 going ex on May 30, 2023
May 31, 2023
Jun 23, 2023
May 30, 2023
Apr 20, 2022
SNY.NB Final Cash Dividend of gross USD 1.74684 paid on May 31, 2022 going ex on May 04, 2022
May 05, 2022
May 31, 2022
May 04, 2022
Mar 24, 2021
SNY.NB Final Cash Dividend of gross USD 1.928784 paid on May 26, 2021 going ex on May 03, 2021
May 04, 2021
May 26, 2021
May 03, 2021
Mar 05, 2020
SNY.NB Final Cash Dividend of gross USD 1.699399 paid on May 26, 2020 going ex on Apr 30, 2020
May 01, 2020
May 26, 2020
Apr 30, 2020
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
